急性髓系白血病中表观遗传和遗传多样性的独立性。 - Suppr | 超能文献

相似文献

1

Independence of epigenetic and genetic diversity in AML.急性髓系白血病中表观遗传和遗传多样性的独立性。

Nat Med. 2016 Jul 7;22(7):708-9. doi: 10.1038/nm.4136.

2

Epigenetic Achilles' heel of AML.急性髓系白血病的表观遗传阿喀琉斯之踵。

Nat Cancer. 2021 May;2(5):481-483. doi: 10.1038/s43018-021-00212-w.

3

Genetic and epigenetic determinants of AML pathogenesis.AML 发病机制的遗传和表观遗传决定因素。

Semin Hematol. 2019 Apr;56(2):84-89. doi: 10.1053/j.seminhematol.2018.08.001. Epub 2018 Aug 22.

4

The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia.表观遗传学治疗在骨髓增生异常综合征和急性髓系白血病中的进展。

Semin Hematol. 2021 Jan;58(1):56-65. doi: 10.1053/j.seminhematol.2020.12.003. Epub 2020 Dec 28.

5

Clinical developments in epigenetic-directed therapies in acute myeloid leukemia.急性髓系白血病中表观遗传定向疗法的临床进展

Blood Adv. 2020 Mar 10;4(5):970-982. doi: 10.1182/bloodadvances.2019001245.

6

Targeting AML at the intersection of epigenetics and signaling.靶向表观遗传学和信号转导的 AML。

Sci Signal. 2022 Apr 19;15(730):eabo0059. doi: 10.1126/scisignal.abo0059.

7

[Epigenetic dysregulation in myelodysplastic syndrome].[骨髓增生异常综合征中的表观遗传失调]

Rinsho Ketsueki. 2015 Feb;56(2):111-8. doi: 10.11406/rinketsu.56.111.

8

The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.PRMT5在急性髓系白血病中的双重表观遗传作用：通过组蛋白精氨酸甲基化实现基因激活和抑制。

Leukemia. 2016 Apr;30(4):789-99. doi: 10.1038/leu.2015.308. Epub 2015 Nov 5.

9

Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities.当前和新兴的急性髓细胞白血病的分子和表观遗传学疾病实体及其治疗方式的批判性评估。

Semin Cancer Biol. 2022 Aug;83:121-135. doi: 10.1016/j.semcancer.2020.11.010. Epub 2020 Nov 23.

10

Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.识别高危成年急性髓系白血病患者：表观遗传和遗传风险因素及其对治疗的影响。

Expert Rev Hematol. 2016;9(4):351-60. doi: 10.1586/17474086.2016.1141673. Epub 2016 Feb 12.

引用本文的文献

1

The evolutionary theory of cancer: challenges and potential solutions.癌症的进化理论：挑战与潜在解决方案。

Nat Rev Cancer. 2024 Oct;24(10):718-733. doi: 10.1038/s41568-024-00734-2. Epub 2024 Sep 10.

2

Abnormal regulation of miR-29b-ID1 signaling is involved in the process of decitabine resistance in leukemia cells.miR-29b-ID1 信号的异常调节参与了白血病细胞中地西他滨耐药的过程。

Cell Cycle. 2023 May;22(10):1215-1231. doi: 10.1080/15384101.2023.2200312. Epub 2023 Apr 9.

3

Overexpression of ZEB2-AS1 lncRNA is associated with poor clinical outcomes in acute myeloid leukemia.

本文引用的文献

1

Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia.急性髓系白血病中表观遗传和基因异质性的独特演变及动态变化

Nat Med. 2016 Jul;22(7):792-9. doi: 10.1038/nm.4125. Epub 2016 Jun 20.

2

Single-cell genome sequencing: current state of the science.单细胞基因组测序：科学现状。

Nat Rev Genet. 2016 Mar;17(3):175-88. doi: 10.1038/nrg.2015.16. Epub 2016 Jan 25.

3

Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.年轻成人急性髓系白血病的分子图谱及其临床相关性。